The rising preference of patients not using a syringe is anticipated to help the Global “Needle-Free Drug Delivery Technology Market” in the forecast years. The above information was shared by Fortune Business Insights in a report, titled “Needle-free Drug Delivery Technology Market Size, Share and Global Trend By Product (Inhaler, Jet Injector, Novel Needles, Transdermal Patch), By Application (Vaccine Delivery, Pain Management, Insulin Delivery), By End Users (Hospitals Clinics, Homecare Settings, Research Laboratories, Academics), and Geography Forecast till 2026.” The research report gives an entire study of the Needle-free Drug Delivery Technology Market leaders with key statistics like sales, revenue, price, product picture and specifications, contact information, cost, capacity, production and company profile.
One of the primary reasons for people not opting for syringes is the risk associated with their contamination. Needle-free drug delivery technology offers several advantages than conventional syringes. Some of the benefits include ensuring proper dosage, cost-effectiveness, faster administration, and less pain. Driven by these benefits, the demand for needle-free drug delivery technology is likely to increase over the projected horizon.
Request a Sample Copy of the Research Report:
Enormous Benefits Offered by Needle-free Drug Delivery Devices Drives the Market
Recent technological developments in the healthcare sector are likely to pave the way for the entry of new market players. These players are likely to adopt these devices in applications such as Ataxic Cerebral Palsy, AIDS, and cancer. Polycarbonate materials are used in needle-free drug injectors as these materials are tough, lightweight, and flexible. Considering this, QS Medical Technology Company manufactures a novel needle-free injection delivery device for insulin in September 2018.
Faster administration of needle-free drug injector leads to less pain and improves the patient outcome. These factors are expected to play an instrumental role in propelling the growth of the market. Faster administration has a faster effect of drugs on the human body. This, coupled with the cost-effectiveness of these drugs, is expected to drive the market.
Portal Instrument’s Needle-free Drug Delivery Injector Completes its Commercialization Deal
Companies in the global needle-free drug delivery technology market are getting recognized as they are making several strategic decisions. For instance, PharmaJet received a recognition award for developing needle-free drug delivery technology. The company received the Global Technology Innovation Award in October 2018. A start-up called Portal Instruments collaborates with Japanese pharmaceutical key players in December 2017. This collaboration aims at developing and commercializing the device called PRIME. This needle-free injection device enabled with smart technology is smart helps to reduce the anxiety and pain associated with injections. The company further aims to improve patient adherence with the introduction of this device.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Needle-free Drug Delivery Technology Market. Please visit: https://www.fortunebusinessinsights.com/industry-reports/needle-free-drug-delivery-technology-market-100676